Blog

USP: Over the past few decades, the supply chain for pharmaceuticals and their ingredients has expanded around the world, and so has the presence of substandard and counterfeit products. Notable adverse events related to poor quality medicines (e.g., heparin and glycerin contamination) have brought increased attention from policymakers, regulators, manufacturers, and consumers to the threat of using poor quality medicines.

Medicine counterfeiting is first and foremost a crime against patients. By deliberately and deceitfully attempting to pass themselves off as something that they are not, namely, genuine approved medicines, counterfeit medicines pose a global public health risk, leading to resistance to treatment, illness, disability and even death. See more IFPMA principles by downloading IFPMA Ten Principles.

ACT: if you are a doctor, you can help your patients avoid counterfeit health products by focusing on several points during the medical visit. AGIR : si  vous êtes un médecin vous pouvez aider vos patients a éviter les contrefaçons de produits de santé en insistant sur plusieurs points durant la visite médicale. Pour en savoir plus, cliquez ici.

Counterfeit medicines are a serious threat to the health of individuals. The harm for individuals can be generated either by excessive activity of the principal active ingredient, by an insufficient dosage of active ingredient or by the toxicity of ingredients that should not be present in the medicine. Patients may also believe that they are protected against a disease or an undesired health event when in fact they are not, or that they are receiving Read more…

IRACM – Geographic Observatory : if you want to have a view on the spread of fake medicines, have a look at IRACM  Seizures Map. IRACM-Observatoire Géographique : si vous voulez connaitre l’ampleur du phénomène des faux médicaments regardez la Carte de Saisie de l’IRACM ici.